Skip to content
mp.weixin.qq.com·· 9 hours agoPickScore70

GV-971 Remodels Gut Redox Adaptation to Ease Alzheimer's Disease in Gut Study

In brief

On October 23, 2026, Meiyu Geng's team published a study in Gut showing that sodium oligomannate (GV-971) alleviates Alzheimer's disease by remodeling gut redox adaptation and promoting microbiota-derived indole-3-propionic acid production. Responders had a more reduced gut environment, and fecal microbiota transplantation transferred the benefit to 5xFAD mice. Sodium oligomannate is a microbiome-centered therapy for Alzheimer's disease in China, but its clinical efficacy varies.

Why it matters

The paper links gut redox shifts and increased microbiota-derived indole-3-propionic acid to benefits in 5xFAD mice, with transplant results supporting microbiome involvement.

Source: mp.weixin.qq.com · mp.weixin.qq.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.